Immunofluorescence with anti--H2AX immunostaining, coupled with telomere-or 155 centromere-FISH were performed to assess if telomeres and centromeres were affected. In 156 interphase, both telomeres and centromeres were damaged in K243R/+ and p53-/-, predominant mutation type with T>C, A>G, G>A, and C>T changes being most common, 201 followed by T>G and A>C (Fig. 3C ). This spectrum was broadly similar among K243R/+, 202 p53-/-, and K243R/+;p53-/-tumor cells. The total numbers of SNVs were 5,140 in K243R/+ 203 tumor cells, 6,801 in p53-/-cells, and 14,022 in K243R/+;p53-/-cells, respectively. (Fig. 3C,   204 left). However, G>T and C>A mutations were relatively frequent in p53-/-cells, and T>C 205 mutations were most frequent in K243R/+ tumor cells ( Fig. 3C, right) . The results suggest 206 that genetic instability, reflected by random point mutations accompany the loss of BubR1 207 acetylation in tumorigenesis.
209
Robertsonian whole-arm translocation is significant in tumors of BubR1 acetylation-210 deficient mice 211 As centromere and telomere were damaged by the loss of BubR1 acetylation in primary 212 MEFs, we asked whether tumors from K243R/+; p53-/-exhibit any further chromosome 213 aberrations related to centromeres and telomeres. When centromere and telomere-FISH were 214 performed in tumor cells, we made an interesting observation: most apparent chromosome 215 aberration was the Robertsonian-like whole-arm translocation that led to X-shaped 216 chromosomes instead of U-shaped telocentric mouse chromosomes in K243R/+; p53-/-cells 217 ( Fig. 4A ). Whole-arm translocation was a significant feature in tumors of K243R/+; p53-/-, 218 but was rarely found in p53-/-tumors ( Fig. 4A, right) .
219
The fusion of two chromosomes at the short arm, but not the long arm, where centromeres 220 and telomeres are proximal to each other generated X-shaped chromosome. At the fused point, centromere specification was unperturbed in the fused chromosomes. Consistently, telomere 224 and centromere fragility were apparent, as were in MEFs ( Fig. 4A , arrows in the inset).
225
Robertsonian whole-arm translocation was a significant feature of the tumors from K243R/+; 226 p53-/-but was rarely detected from p53-/-tumors ( Fig 4A, graph) . These results suggest that 227 the replication stress at the telomeres, caused by the loss of BubR1 acetylation may be the 
Loss of BubR1 acetylation is found in human cancers

236
BubR1 acetylation deficiency in mice leads to tumorigenesis through chromosome mis-237 segregation, due to weakened SAC and failure in the stabilization of chromosome-spindle 238 attachment (11). We further showed here that BubR1 acetylation deficiency results in various 239 types of chromosome structural aberration due to replication stress. 240 We next asked whether BubR1 acetylation deficiency could be found in human cancers. In 241 the cancer genome database (cBioPortal, TCGA), we did not find the exact mutation of K250 242 in BubR1. However, we found nine mutations around K250 of BubR1 from the TCGA 243 database using cBioPortal ( Supplemental Table S1 ) (24-28). monoclonal antibody specific to BubR1 acetylated at K250. Four mutants (Fig. 5A, bottom) 246 that were tested for the capability of BubR1 acetylation are as follows: BubR1 mutation at 247 R244C and G246R, reported from melanomas; A251P mutation from renal cell carcinoma;
248
N255Y mutation from Rhabdomyosarcoma (29, 30) ( Supplemental Table S1 ). Mutant BubR1 249 constructs were generated by site-directed mutagenesis, with Myc tagged at the N-terminus 250 then were transfected into 293T cells. Two days post-transfection, cells were treated with 251 nocodazole to arrest in mitosis, then subjected to immunoprecipitation (IP) with anti-BubR1 
255
The result showed that A251P mutant, which was found from renal cell carcinoma was 256 completely defective in BubR1 acetylation, as was the control K250R (Fig. 5A ). In total cell is likely to be associated with human cancers.
362
Forced expression of the acetylation-mimetic form of BubR1 (K250Q) led to apoptosis in 363 BRCA2-deficient cells (10). Furthermore, BRCA2-deficient cells exhibited resistance to pan-364 HDAC inhibitors because they lack BubR1 acetylation, but was sensitive to a specific type of 365 HDAC inhibitor (8). It would be interesting to see if cancers with defective BubR1 366 acetylation will be sensitive to K250Q-BubR1 expression or a specific type of deacetylase 367 inhibitors.
368
Previously, we have seen that BubR1 level was associated with poor prognostics of Various BubR1 mutants were generated by site-directed mutagenesis using pcDNA3.1-myc-
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Figure legend
from each group were scored in three independent experiments (mean ± SEM; n = 60). P 
